GV 2019, L.P. 13D/13G Filings for Maze Therapeutics, Inc. (MAZE)

GV 2019, L.P. 13D and 13G filings for Maze Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-09
4:15 pm
Purchase
2025-03-3113GMaze Therapeutics, Inc.
MAZE
GV 2019, L.P. 2,412,471
5.500%
2,412,471increase
(New Position)
Filing